Al-Masri, M.; Safi, Y.; Kardan, R.; Mustafa, D.; Ramadan, O.; AlMasri, R.
Adding Neoadjuvant Immunotherapy to Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: A Propensity-Matched Cohort Study from a Tertiary Cancer Center. Cancers 2025, 17, 3933.
https://doi.org/10.3390/cancers17243933
AMA Style
Al-Masri M, Safi Y, Kardan R, Mustafa D, Ramadan O, AlMasri R.
Adding Neoadjuvant Immunotherapy to Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: A Propensity-Matched Cohort Study from a Tertiary Cancer Center. Cancers. 2025; 17(24):3933.
https://doi.org/10.3390/cancers17243933
Chicago/Turabian Style
Al-Masri, Mahmoud, Yasmin Safi, Ramiz Kardan, Daliana Mustafa, Ola Ramadan, and Rama AlMasri.
2025. "Adding Neoadjuvant Immunotherapy to Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: A Propensity-Matched Cohort Study from a Tertiary Cancer Center" Cancers 17, no. 24: 3933.
https://doi.org/10.3390/cancers17243933
APA Style
Al-Masri, M., Safi, Y., Kardan, R., Mustafa, D., Ramadan, O., & AlMasri, R.
(2025). Adding Neoadjuvant Immunotherapy to Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: A Propensity-Matched Cohort Study from a Tertiary Cancer Center. Cancers, 17(24), 3933.
https://doi.org/10.3390/cancers17243933
